202 related articles for article (PubMed ID: 15221424)
41. Medical cannabis vs. synthetic cannabinoids: What does the future hold?
Bolognini D; Ross RA
Clin Pharmacol Ther; 2015 Jun; 97(6):568-70. PubMed ID: 25761845
[TBL] [Abstract][Full Text] [Related]
42. A user's guide to cannabinoid therapies in oncology.
Maida V; Daeninck PJ
Curr Oncol; 2016 Dec; 23(6):398-406. PubMed ID: 28050136
[TBL] [Abstract][Full Text] [Related]
43. Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity?
Blázquez C; Carracedo A; Salazar M; Lorente M; Egia A; González-Feria L; Haro A; Velasco G; Guzmán M
Neuropharmacology; 2008 Jan; 54(1):235-43. PubMed ID: 17675107
[TBL] [Abstract][Full Text] [Related]
44. [The endogenous cannabinoid system. Therapeutic implications for neurologic and psychiatric disorders].
Schneider U; Seifert J; Karst M; Schlimme J; Cimander K; Müller-Vahl KR
Nervenarzt; 2005 Sep; 76(9):1062, 1065-6, 1068-72 passim. PubMed ID: 15776259
[TBL] [Abstract][Full Text] [Related]
45. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group.
; Strasser F; Luftner D; Possinger K; Ernst G; Ruhstaller T; Meissner W; Ko YD; Schnelle M; Reif M; Cerny T
J Clin Oncol; 2006 Jul; 24(21):3394-400. PubMed ID: 16849753
[TBL] [Abstract][Full Text] [Related]
46. Immunoactive effects of cannabinoids: considerations for the therapeutic use of cannabinoid receptor agonists and antagonists.
Greineisen WE; Turner H
Int Immunopharmacol; 2010 May; 10(5):547-55. PubMed ID: 20219697
[TBL] [Abstract][Full Text] [Related]
47. Cannabinoid receptors in atherosclerosis.
Steffens S; Mach F
Curr Opin Lipidol; 2006 Oct; 17(5):519-26. PubMed ID: 16960500
[TBL] [Abstract][Full Text] [Related]
48. Cannabinoids in supportive care: are they necessary?
Bruera E; Castro M
Support Care Cancer; 2003 Mar; 11(3):133-4. PubMed ID: 12618920
[No Abstract] [Full Text] [Related]
49. Cannabis for Pain and Headaches: Primer.
Kim PS; Fishman MA
Curr Pain Headache Rep; 2017 Apr; 21(4):19. PubMed ID: 28281107
[TBL] [Abstract][Full Text] [Related]
50. Medical Cannabinoids for Cancer Cachexia: A Systematic Review and Meta-Analysis.
Wang J; Wang Y; Tong M; Pan H; Li D
Biomed Res Int; 2019; 2019():2864384. PubMed ID: 31341892
[TBL] [Abstract][Full Text] [Related]
51. Immunosuppression by marihuana and its cannabinoid constituents.
Levy JA; Heppner GH
J Immunopharmacol; 1980; 2(2):159-77. PubMed ID: 6821549
[No Abstract] [Full Text] [Related]
52. Cannabinoid exposure during pregnancy and its impact on immune function.
Dong C; Chen J; Harrington A; Vinod KY; Hegde ML; Hegde VL
Cell Mol Life Sci; 2019 Feb; 76(4):729-743. PubMed ID: 30374520
[TBL] [Abstract][Full Text] [Related]
53. Drugs and immunity: cannabinoids and their role in decreased resistance to infectious disease.
Cabral GA; Dove Pettit DA
J Neuroimmunol; 1998 Mar; 83(1-2):116-23. PubMed ID: 9610679
[TBL] [Abstract][Full Text] [Related]
54. Cannabinoids and autoimmune diseases: A systematic review.
Katchan V; David P; Shoenfeld Y
Autoimmun Rev; 2016 Jun; 15(6):513-28. PubMed ID: 26876387
[TBL] [Abstract][Full Text] [Related]
55. Effects of cannabinoids on the immune system and central nervous system: therapeutic implications.
Molina-Holgado E; Guaza C; Borrell J; Molina-Holgado F
BioDrugs; 1999 Nov; 12(5):317-26. PubMed ID: 18031185
[TBL] [Abstract][Full Text] [Related]
56. Targeting astrocytomas and invading immune cells with cannabinoids: a promising therapeutic avenue.
Cudaback E; Stella N
Mol Neurobiol; 2007 Aug; 36(1):36-44. PubMed ID: 17952648
[TBL] [Abstract][Full Text] [Related]
57. Cannabinoids in Medical Practice.
Strouse TB
Cannabis Cannabinoid Res; 2016; 1(1):38-43. PubMed ID: 28861478
[TBL] [Abstract][Full Text] [Related]
58. Self-reported Use of K2/Spice for Appetite Stimulation: A Case Report.
Torres C; Espiridion ED
Cureus; 2020 Apr; 12(4):e7860. PubMed ID: 32483510
[TBL] [Abstract][Full Text] [Related]
59. Cannabinoids and the immune system.
Klein TW; Newton CA; Friedman H
Pain Res Manag; 2001; 6(2):95-101. PubMed ID: 11854771
[TBL] [Abstract][Full Text] [Related]
60. Potential therapeutic applications of naturally occurring and synthetic cannabinoids.
Bhargava HN
Gen Pharmacol; 1978; 9(4):195-213. PubMed ID: 680553
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
